Issue 22 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

32

No.

22

June 09, 2006Jun 09, 2006

Free

DOWNLOAD THE PDF

FDA Approves Merck’s Gardasil Vaccine To Prevent Cervical Cancer.

FDA Roundup: Public Citizen Uses Logic of FDA’s Critical Path to Challenge Decision On Anti-Obesity Drug.

Advocates Oppose Proposals to Market Drugs After Phase I.

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

House Subcommittee Passes Bush Request for NIH, NCI Budgets.

NCI: The Times Have Been “Confusing,” Acting NCI Director Niederhuber Admits in Memo.

Recent Issues

Volume 52 | Issue 09 - March 06, 2026

Volume 52 | Issue 08 - February 27, 2026

Volume 52 | Issue 07 - February 20, 2026

Volume 52 | Issue 06 - February 13, 2026

Volume 52 | Issue 05 - February 06, 2026

Volume 52 | Issue 04 - January 30, 2026